Back
Arcus Biosciences, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
19
RCUS
Arcus Biosciences, Inc.
Last Price:
$22.29
Seasonality Move:
4.68%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$54.77
Seasonality Move:
14.46%
Sell
19
Arcus Biosciences, Inc. (RCUS)
is a Sell
Is Arcus Biosciences, Inc. a Buy, Sell or Hold?
-
The current Arcus Biosciences, Inc. [RCUS] share price is $22.28. The Score for RCUS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
RCUS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $54.74. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCUS Stock Price Chart
What is Arcus Biosciences, Inc.'s stock price today?
-
The Arcus Biosciences, Inc. share price today is $22.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCUS is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $54.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
RCUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.78 | Buy |
| Relative Strength Index (14 RSI): | 47.43 | Sell |
| Chaikin Money Flow: | 632286 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.87 - 25.51) | Sell |
| Bollinger Bands (100): | (10.53 - 21.27) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 45.45 | Sell |
| Chaikin Money Flow: | -1078798 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.55 - 56.85) | Buy |
| Bollinger Bands (100): | (52.52 - 65.44) | Sell |
RCUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.67 | Sell |
| 20-day SMA: | 23.99 | Sell |
| 50-day SMA: | 20.61 | Buy |
| 200-day SMA: | 12.34 | Buy |
| 8-day EMA: | 4.95 | Buy |
| 20-day EMA: | 2.12 | Buy |
| 50-day EMA: | 0.87 | Buy |
| 200-day EMA: | 0.22 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.72 | Sell |
| 20-day SMA: | 54.52 | Buy |
| 50-day SMA: | 59.78 | Sell |
| 200-day SMA: | 50.98 | Buy |
| 8-day EMA: | 56.04 | Sell |
| 20-day EMA: | 55.88 | Sell |
| 50-day EMA: | 56.44 | Sell |
| 200-day EMA: | 37.2 | Buy |
Arcus Biosciences, Inc. Earnings Growth & RCUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.37 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Arcus Biosciences, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||